Fisher & Paykel Healthcare Corporation Limited · NZX:FPH
Fisher & Paykel Healthcare — Shareholder Meeting (August 2023)
44 slides from Fisher & Paykel Healthcare's shareholder meeting presentation, Aug 29, 2023
Slide 1: News Release: 2023 Annual Shareholders' Meeting Speech and Presentation
News Release STOCK EXCHANGE LISTINGS: NEW ZEALAND (FPH), AUSTRALIA (FPH) 2023 Annual Shareholders’ Meeting Speech and Presentation Auckland, New Zealand, 29 August 2023 – Fisher & Paykel Healthcare Corporation Limited has provided the attached Chair’s speech and CEO’s slide presentation for the 2023
Slide 2: Address by Scott St John, Chair
FISHER & PAYKEL HEALTHCARE CORPORATION LIMITED ANNUAL SHAREHOLDERS’ MEETING 29 AUGUST 2023 ADDRESS BY SCOTT ST JOHN, CHAIR I’d like to begin my remarks by thanking our customers, clinical partners and our people. Last year, approximately 20 million patients were treated with Fisher & Paykel Healthca
Slide 3: Chair's address: infrastructure, ESG and board changes
Turning to the present, we updated the market this morning with our latest line of sight for the 2024 financial year. Lewis will take you through that in more detail shortly. Setting financials aside for a moment, there have been a number of significant milestones elsewhere. We’ve taken some big str
Slide 4: Board succession and director appointment
We are confident Graham will add a valuable perspective to your Board. Graham will commence as a director on 1 October, and given that the appointment process was completed after this year’s Notice of Meeting was circulated, his appointment will be put to shareholders for their consideration at next
Slide 5: For personal use only
Fisher &Paykel HEALTHCARE N) N (e) N {e)) c a] a) oO = ‘w ra oO 3s ie) ra oO Ne © c Yn © 5 c Cc <
Slide 6: Online Help
For personal use only Online Help Fisher &Paykel HEALTHCARE
Slide 7: Your Board
For personal use only Your Board Scott St John BY Lisa McIntyre BB® Lewis Gradon Sir Michael Daniell Pip Greenwood */ y Neville Mitchell Donal O’Dwyer Cather Simpson Fisher &Paykel HEALTHCARE
Slide 8: Agenda
For personal use only Agenda Chair’s Address and Board Subcommittee Updates Managing Director and Chief Executive Officer’s Address Financial Statements Resolutions Voting General Questions Fisher &Paykel HEALTHCARE
Slide 9: Scott St John, Board Chair
For personal use only Scott St John Board Chair Fisher &Paykel HEALTHCARE
Slide 10: FY2023 Financial Highlights
FY2023 Financial Highlights ~, Operating Revenue $1.58B -6% Net Profit After Tax $250.3m -34% For personal use onl
Slide 11: Hospital product group
For personal use only Hospital product group $1207.1M 42.5M iz Airvo 3 Fisher &Paykel HEALTHCARE
Slide 12: Homecare product group
For personal use only Homecare product group FY23 HOMECARE OPERATING REVENUE CONSTANT Guereniey 1) 1 —7 $45/.5M FY19 FY20 FY21 FY22 FY23 Evora Full Fisher &Paykel HEALTHCARE
Slide 13: Long term gross margin and operating margin targets
For personal use only Long Term Gross Margin target Long Term Operating Margin target
Slide 14: Dividend History
For personal use only • • DIVIDEND HISTORY
Slide 15: Scott St John, Board Chair
For personal use only Scott St John 1 Board Chair Fisher&.Paykel HEALTHCARE
Slide 16: Your Board
For personal use only Your Board Scott St John BY Lisa McIntyre BB® Lewis Gradon Sir Michael Daniell Pip Greenwood */ y Neville Mitchell Donal O’Dwyer Cather Simpson Fisher &Paykel HEALTHCARE
Slide 17: Neville Mitchell, Audit & Risk Committee Chair
For personal use only Neville Mitchell Audit & Risk Committee Chair Fisher&.Paykel HEALTHCARE
Slide 18: Lisa McIntyre, People & Remuneration Committee Chair
For personal use only Lisa McIntyre People & Remuneration Committee Chair Fisher&.Paykel HEALTHCARE
Slide 19: Mike Daniell, Quality, Safety & Regulatory Committee Chair
For personal use only Mike Daniell Quality, Safety & Regulatory Committee Chair Fisher&.Paykel HEALTHCARE
Slide 20: Scott St John, Board Chair
For personal use only Scott St John Board Chair Fisher&.Paykel HEALTHCARE
Slide 21: Donal O'Dwyer, Director
For personal use only Donal O’Dwyer Director Fisher&.Paykel HEALTHCARE
Slide 22: Lewis Gradon, Managing Director and CEO
For personal use only Lewis Gradon Managing Director and CEO Fisher&.Paykel HEALTHCARE
Slide 23: Connection video
For personal use only Connection video Fisher&.Paykel HEALTHCARE
Slide 24: FY24 Financial Outlook
FY24 Financial Outlook First Half ~ At 31 July 2023 exchange rates*, and assuming a continuation of trading conditions in the first —} four months, the company expects: * Operating revenue to be approximately $790 million. * Net profit after tax to be within the range of approximately $95 million to
Slide 25: Our growth opportunities
4 Our growth For personal use only opportunitie HEALTHCARE
Slide 26: Applications outside of invasive ventilation
For personal use only Invasive Noninvasive Hospital Home Respiratory Obstructive Sleep Respiratory Support Anesthesia Support Apnea Ventilation Ventilation Infant Care Surgical Applications outside of invasive ventilation
Slide 27: Long-term growth aspirations
For personal use only The image above is an illustration of the company’s long-term growth aspirations. It is not a graph and should not be interpreted as being indicative of levels of revenue or profitability in the short term.
Slide 28: For personal use only
For personal use only • • • • • • • • • •
Slide 29: Gross margin and operating (EBIT) margin
GROSS MARGIN OPERATING (EBIT) MARGIN For personal use only 70% 40% 60% 35% 30% 50% 25% 40% 20% 30% 15% 20% 10% 10% 5% 0% 0% FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21 FY22 FY23 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21 FY22 FY23 Long Term Gross Margin target Long Term Operating Margin target
Slide 30: Continuous improvement
For personal use only Continuous improvement oO A ur Global Cl wards 2023 Projected total Cl initiatives for 2023 Total for 2019 Fisher & Paykel HEALTHCARE
Slide 31: For personal use only
For personal use only • • • • • • •
Slide 32: Scott St John, Board Chair
For personal use only Scott St John Board Chair Fisher&.Paykel HEALTHCARE
Slide 33: Financial Statements
For personal use only Financial Statements Opportunity for shareholders to ask any questions specifically on the financial statements, the auditor’s report or the company’s 2023 annual report. There will be an opportunity to ask any general questions once all items on the agenda have been considered
Slide 34: Resolutions
For personal use only Resolutions NO = ON Ww Re-election of Pip Greenwood Auditor’s Remuneration Director’s Remuneration Issue of Performance Share Rights Issue of Options Fisher &Paykel HEALTHCARE
Slide 35: Voting box, Question box
For personal use only Voting box Question box
Slide 36: Resolution 1: Re-election of Pip Greenwood
Resolution 1: Re-election of Pip Greenwood That Pip Greenwood, who retires by > rotation and, being eligible, offers herself 5 for re-election, be re-elected as a director Y of the Company. Click “Submit Vote” to lodge your vote. Need help? Call the Link Market Services helpline 0800 200 220 For per
Slide 37: Pip Greenwood, Director
For personal use only Pip Greenwood Director Fisher &Paykel HEALTHCARE
Slide 38: Resolution 1: Re-election of Pip Greenwood
Resolution 1: Re-election of Pip Greenwood That Pip Greenwood, who retires by > rotation and, being eligible, offers herself 5 for re-election, be re-elected as a director Y of the Company. Click “Submit Vote” to lodge your vote. Need help? Call the Link Market Services helpline 0800 200 220 For per
Slide 39: Resolution 2: Auditor's Remuneration
Resolution 2: Auditor’s Remuneration That the Directors be authorised to fix the _> fees and expenses of PwC as the 7 Company’s auditor. Click “Submit Vote” to lodge your vote. Need help? Call the Link Market Services helpline 0800 200 220 For personal use Fisher &Paykel HEALTHCARE
Slide 40: Resolution 3: Director's Remuneration
Resolution 3: Director’s Remuneration That the maximum aggregate annual remuneration payable to non-executive 7 Directors be increased by NZ$295,000 2 from NZ$1,455,000 to NZ$1,750,000 (plus = GST as appropriate) be approved. Click “Submit Vote” to lodge your vote. Need help? Call the Link Market Se
Slide 41: Resolution 4: Issue of Performance Share Rights
Resolution 4: Issue of Performance Share Rights That approval be given for the issue of up to 100,000 performance share rights under the Fisher & Paykel Healthcare 2022 Performance Share Rights Plan to Lewis Gradon, Managing Director and Chief Executive Officer of the Company. For personal use only
Slide 42: Resolution 5: Issue of Options
Resolution 5: Issue of Options That approval be given for the issue of up > to 190,000 options under the 7 Fisher & Paykel Healthcare 2022 Share 2 Option Plan to Lewis Gradon, Managing Director and Chief Executive Officer of the Company. Click “Submit Vote” to lodge your vote. Need help? Call the Li
Slide 43: Fisher & Paykel Healthcare
Ajuo asn s;euosied Jo4 ykel HEALTHCARE Fisher &Par
Slide 44: This concludes the 2023 Annual Shareholders' Meeting
For personal use only This concludes the 2023 _ Annual Shareholders’ Meeting. Thank you for attending Fisher &Paykel HEALTHCARE
Fisher & Paykel Healthcare — Shareholder Meeting (August 2023) on 6ix